Elizabeth Barrett - Jan 31, 2022 Form 4 Insider Report for UroGen Pharma Ltd. (URGN)

Role
Chief Executive Officer
Signature
/s/ Jason Smith, Attorney-in-Fact
Stock symbol
URGN
Transactions as of
Jan 31, 2022
Transactions value $
-$62,118
Form type
4
Date filed
2/2/2022, 03:32 PM
Previous filing
Jan 7, 2022
Next filing
Jun 17, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction URGN Ordinary Shares Options Exercise +5K +1.68% 303K Jan 31, 2022 Direct F1
transaction URGN Ordinary Shares Sale -$16.9K -2.24K -0.74% $7.58 301K Jan 31, 2022 Direct F2
transaction URGN Ordinary Shares Options Exercise +13.3K +4.43% 314K Jan 31, 2022 Direct F1
transaction URGN Ordinary Shares Sale -$45.2K -5.96K -1.9% $7.58 308K Jan 31, 2022 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction URGN Restricted Stock Units Options Exercise $0 -5K -50% $0.00 5K Jan 31, 2022 Ordinary Shares 5K Direct F1, F3
transaction URGN Restricted Stock Units Options Exercise $0 -13.3K -33.33% $0.00 26.7K Jan 31, 2022 Ordinary Shares 13.3K Direct F1, F4
transaction URGN Stock Option (right to buy) Award $0 +150K $0.00 150K Jan 31, 2022 Ordinary Shares 150K $7.72 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer
F2 Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units
F3 The reporting person was granted restricted stock units ("RSUs") on January 31, 2020 representing 15,000 ordinary shares. The RSUs vest in three equal annual installments from January 31, 2021.
F4 The reporting person was granted restricted stock units ("RSUs") on January 31, 2021 representing 40,000 ordinary shares. The RSUs vest in three equal annual installments from January 31, 2022.
F5 1/3 of the shares underlying the stock options will vest on each of January 31, 2023, January 31, 2024 and January 31, 2025